Editorial : Impact of COVID-19 on HIV/STI screening, prevention, and treatment
| dc.contributor.author | Pyra, Maria | |
| dc.contributor.author | Mahasha, Phetole | |
| dc.date.accessioned | 2024-06-26T10:36:44Z | |
| dc.date.available | 2024-06-26T10:36:44Z | |
| dc.date.issued | 2023-07-17 | |
| dc.description.abstract | No abstract available. | en_US |
| dc.description.department | Nuclear Medicine | en_US |
| dc.description.librarian | am2024 | en_US |
| dc.description.sdg | SDG-03:Good heatlh and well-being | en_US |
| dc.description.uri | https://www.frontiersin.org/journals/reproductive-health# | en_US |
| dc.identifier.citation | Pyra, M. & Mahasha, P.W. (2023) Editorial: Impact of COVID-19 on HIV/STI screening, prevention, and treatment. Frontiers in Reproductive Health 5:1228325. DOI: 10.3389/frph.2023.1228325. | en_US |
| dc.identifier.issn | 2673-3153 (online) | |
| dc.identifier.other | 10.3389/frph.2023.1228325 | |
| dc.identifier.uri | http://hdl.handle.net/2263/96676 | |
| dc.language.iso | en | en_US |
| dc.publisher | Frontiers Media | en_US |
| dc.rights | © 2023 Pyra and Mahasha. This is an openaccess article distributed under the terms of the Creative Commons Attribution License (CC BY). | en_US |
| dc.subject | Testing | en_US |
| dc.subject | Human immunodeficiency virus (HIV) | en_US |
| dc.subject | COVID-19 pandemic | en_US |
| dc.subject | Coronavirus disease 2019 (COVID-19) | en_US |
| dc.subject | Pandemic | en_US |
| dc.subject | Sexually transmitted infection (STI) | en_US |
| dc.subject | SDG-03: Good health and well-being | en_US |
| dc.subject | Editorial | |
| dc.title | Editorial : Impact of COVID-19 on HIV/STI screening, prevention, and treatment | en_US |
| dc.type | Article | en_US |